May 29, 2020 · 7:00 AM
From a latest Diabetes Care article:
Our information recommend sturdy advantages for renal outcomes, coronary heart failure, and CV mortality after GBP in people with weight problems and T2DM. These outcomes recommend that marked weight loss yields essential advantages, significantly on the cardiorenal axis (together with slowing development to end-stage renal illness), regardless of the baseline renal perform standing.
Because of the chance of surgical procedure, I’d be certain that first that weight-reduction plan modification was severely tried and failed.
Steve Parker, M.D.